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Abstract. 
 
Cytokines and extracellular matrix proteins 
initiate signaling cascades that regulate cell migration 
and proliferation. Evidence is provided that the adap-
tor protein Shc can differentially regulate these pro-
cesses. Speciﬁcally, under growth factor–limiting condi-
tions, Shc stimulates haptotactic cell migration without 
affecting anchorage-dependent proliferation. However, 
when growth factors are present, Shc no longer inﬂu-
ences cell migration; rather, Shc is crucial for DNA syn-
thesis. Mutational analysis of Shc demonstrates that, 
while tyrosine phosphorylation is required for both 
DNA synthesis and cell migration, the switch in Shc sig-
naling is associated with differential use of Shc’s phos-
photyrosine interacting domains; the PTB domain reg-
ulates haptotaxis, while the SH2 domain is selectively 
required for proliferation.
Key words: Shc • cell migration • mitogenesis • SH2
• PTB
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 migration and proliferation are essential to an-
giogenesis, embryonic development and wound
healing. It has become clear that cell migration and
proliferation depend on intracellular signals propagated
by growth factors and adhesion proteins within the ex-
 
tracellular matrix (ECM)
 
1
 
. However, cell migration and
DNA synthesis do not necessarily occur simultaneously.
For example, neural crest cells migrate over long distances
in the embryo yet fail to proliferate (Perris, 1997). During
wound repair, keratinocytes migrate into the wound be-
fore entry into the cell cycle (Martin, 1997). Recent studies
have determined that cell migration and proliferation uti-
lize many of the same intracellular signaling pathways
such as activation of Rho family proteins and the extracel-
lular signal-related matrix (ERK) cascade (Pages et al.,
1993; Olson et al., 1995; Anand-Apte et al., 1997; Klemke
et al., 1997). However, signaling molecules likely exist that
allow cells to differentially regulate cell migration and pro-
liferation. Evidence is provided in this report that the
adaptor protein Shc serves such a purpose.
The Shc family of adaptor proteins consists of multiple
protein-protein interaction domains: an amino-terminal
phosphotyrosine binding (PTB) domain a central collagen
homology (CH) domain and a carboxy-terminal Src ho-
mology 2 (SH2) domain (Pelicci et al., 1992; Blaikie et al.,
1994). Shc exists in three isoforms of 46, 52, and 66 kD,
and was found to associate with and became tyrosine
phosphorylated by the EGF receptor and to be capable of
inducing anchorage-independent growth (Pelicci et al.,
1992). After growth factor stimulation, p52 Shc is re-
cruited to activated tyrosine kinase receptors through ei-
ther its PTB or its SH2 domain, which leads to phosphory-
lation at tyrosine residues 239, 240, and 317 within the CH
domain (Rozakis-Adcock et al., 1992; Gotoh et al., 1996;
van der Geer et al., 1996). Tyrosine-phosphorylated Shc
thus is able to recruit Grb2/SOS through a binding event
between the Grb2 SH2 domain and Shc phosphotyrosine
residues (Pelicci et al., 1992; Rozakis-Adcock et al., 1992),
ultimately resulting in activation of Ras, the ERK cascade,
and mitogenesis (Bonfini et al., 1996). Recent reports
demonstrate that Shc also potentiates integrin signaling.
For example, integrin ligation results in activation of ty-
rosine kinases such as Src, Fyn, and focal adhesion kinase
 
(FAK) that phosphorylate Shc leading to Ras activation
and entry into the cell cycle (McGlade et al., 1992; Mainiero
et al., 1995; Wary et al., 1996, 1998; Schlaepfer et al., 1998).
In addition to their role in regulating DNA synthesis,
growth factor receptors and integrins play a crucial role in
cell migration and invasion (Klemke et al., 1994; Hutten-
locher et al., 1995). This process involves rearrangement of
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the actin cytoskeleton, the formation of new integrin sub-
stratum contacts, cell contraction, and release of preexist-
ing cell–matrix contacts at the trailing edge (Lauffenburger
and Horwitz, 1996). Previous reports have suggested a role
for Shc in this process (Pelicci et al., 1995; Nolan et al.,
1997). Therefore, experiments were designed to evaluate
the role of Shc in cell migration and DNA synthesis. In this
report, evidence is presented that Shc plays a critical role in
regulating these cell biological events. Shc is required for
cell migration, but not proliferation, when growth factors
are limiting. However, in the presence of growth factors
Shc no longer influences cell migration, but rather, is essen-
tial for DNA synthesis. A mutational analysis of Shc has
helped to elucidate how a given adaptor protein can differ-
entially activate cell migration and proliferation.
 
Materials and Methods
 
Antibodies and Reagents
 
Rabbit polyclonal antibodies to Shc were purchased from Transduction
Laboratories. Mouse monoclonal Shc antibodies were from Santa Cruz
Biotechnology. Anti-phosphotyrosine antibodies (4G10) were from Up-
state Biotechnology. Shc cDNAs subcloned into pCDNA3.1HisC were
previously described (Ricketts et al., 1999). TRITC-conjugated phalloidin
was obtained from Sigma. 6F1 was a gift of Dr. Virgil Woods (UCSD, La
Jolla, CA) and mAb 1973Z was obtained from Chemicon.
 
Cell Culture
 
FG-M cells were maintained in RPMI supplemented with 10% FBS, 1 
 
m
 
g/
ml gentamicin, and 0.4 mM glutamine (gentamycin/glutamine; Sigma).
Cells were used from passage 8 to passage 13. Cos-7 cells were maintained
in DME supplemented with 10% FBS, 0.4 mM glutamine, and 1 
 
m
 
g/ml
gentamicin. Cells were used from passage 6 to passage 20 and were myco-
plasma free during the course of these studies.
 
Transfection
 
Cells were transfected with 
 
lac z
 
 (to identify transfected cells) and the in-
dicated constructs on 10-cm tissue culture plates using LipofectAMINE
(GIBCO BRL) per the manufacturer’s instructions. Cos-7 cells were incu-
bated in the transfection mixture for 5 to 7 h and FG-M cells were allowed
to incubate for 15 h. At the end of this time, cells were returned to full
growth medium for either 15 h (Cos-7 cells) or 8 h (FG-M) cells, and se-
rum deprived for 20–24 h before use in experiments.
 
Generation of p52 Shc Stable Cell Line
 
Cos-7 cells were transfected with wild-type, murine p52 Shc cDNA sub-
cloned into pCDNA3.1HisC using LipofectAMINE per the manufac-
turer’s instructions. 3 d later, cells were passaged into growth medium sup-
plemented with 500 
 
m
 
g/ml G418 to select for p52 Shc-expressing cells.
After selection, cells were seeded at low density into 96-well plates, single
colonies were isolated with a cloning ring, and expanded for two passages
before experimental use.
 
Immunofluorescence
 
Acid-washed coverslips were coated with collagen (10 
 
m
 
g/ml) and non-
specific binding was blocked with 0.5% RIA grade BSA (Sigma). Se-
rum-deprived cells were harvested as described below and seeded onto
collagen-coated coverslips. Cells were allowed to spread for 2 h, then
were fixed in 3.7% formaldehyde in PBS, permeabilized for 1 min in
0.01% Triton X-100, and actin was visualized by incubating the cover-
slips for 1 h with 2 
 
m
 
g/ml rhodamine conjugated phalloidin (Sigma).
Coverslips were washed three times in PBS and three times in deionized
water then mounted with gelvatol. Images were acquired with Bio-Rad
MRC1024 confocal system using Bio-Rad Lasersharp software and a
63
 
3
 
 objective on a Zeiss Axiovert 100. Images were processed with
Adobe Photoshop.
 
Migration Assays
 
Motility experiments were performed as previously described (Klemke et
al., 1998). In brief, Boyden chambers (Millipore Millicells, 8-mm pore
size) were coated on either their lower surfaces with 10 
 
m
 
g/ml of the indi-
cated extracellular matrix proteins for 2 h at 37
 
8
 
C. Chambers were then
placed in 24-well culture dishes containing either serum-free DME sup-
plemented with gentamicin, glutamine, and 0.5% BSA (RIA grade, “mi-
gration buffer”; Sigma) or migration buffer supplemented with 100 ng/ml
EGF (mouse receptor grade; UBI) or 25 mg/ml insulin (human recombi-
nant insulin; Boehringer Mannheim Biochemica) as indicated. Cells were
harvested in buffer consisting of Hanks’ balanced salt solution, 25 mM
Hepes, 5 mM EDTA, and 0.01% trypsin. Next, cells were washed twice in
serum-free DME containing 0.5% BSA and 150,000 cells were loaded into
the upper portion of the Boyden chambers. Migrations were allowed to
proceed for 4–6 h. At the end of this time, nonmigratory cells were re-
moved with a cotton swab, and chambers were stained for 
 
b
 
-galactosidase
activity (to identify transfected cells) or stained with crystal violet. Migra-
tion was quantitated by blind counting the number of migratory cells on
the lower surface of the membrane of at least two fields per chamber using
a 20
 
3
 
 objective. Statistical analysis was performed using InStat (Graph
Pad) by pooling the data from multiple independent experiments.
 
Modified Migration Assays
 
Integrin antibody blocking experiments were performed as described
above except that Cos-7 cells were mixed with the indicated anti-integrin
antibodies immediately before loading into Boyden chambers; experi-
ments were then allowed to proceed as above for 4 h. Random migration
experiments were performed using chambers that had been coated with
extracellular matrix protein on either their lower surfaces (haptotaxis) or
their upper and lower surfaces (random migration). Video time-lapse mi-
croscopy was also attempted to assess random migration in serum-
deprived cells on extracellular matrix protein; however, during the course
of the experiment (6 h), Cos-7 cells did not migrate using this method.
 
Replating Assays, Immunoprecipitation, and
Western Blotting
 
Petri dishes were coated with extracellular matrix proteins as indicated.
Nonspecific binding of cells to plates were blocked by incubating with
heat-denatured BSA for 30 min. Next, serum-deprived cells were har-
vested as described above and either left in suspension for 20 min or
plated onto matrix-coated, blocked plates for the indicated times and har-
vested in a lysis buffer containing 10 mM Tris, pH 7.6, 150 mM sodium
chloride, 0.1% SDS, 1% sodium deoxycholate, 1% Triton X-100, and 5 mM
EDTA. The following inhibitors were added immediately before use:
complete protease inhibitor (1 tablet/20 ml; Boehringer Mannheim), 1 mM
PMSF, 2.5 mM sodium orthovanadate. Shc was either immunoprecipi-
tated using a polyclonal Shc antibody (Transduction Labs) or His-tagged
Shc was isolated using nickel agarose beads (Ni-NTA agarose; Qiagen).
Phosphotyrosine was detected using the monoclonal anti-phosphotyrosine
antibody, 4G10. Shc was detected using a either a monoclonal or a poly-
clonal Shc antibody. Bands were visualized by chemiluminescence (Super
Signal; Pierce). Expression levels of Shc mutants in migration assays was
determined by reserving an aliquot of cell lysate from the migration assay
and analyzing it by Western blot with a polyclonal Shc antibody.
 
DNA Synthesis Assay
 
Cells were transfected as described above on coverslips. 24 h later, cells
were serum starved overnight and stimulated with either serum-free DME
or DME containing 100 ng/ml EGF. 12 h later, cells were incubated for an
additional 6 h with bromodeoxyuridine (BrdU) to identify newly synthe-
sized DNA. Coverslips were then washed with PBS and fixed in 3.7%
formaldehyde. BrdU was quantitated in transfected cells by staining with
a rat anti-BrdU antibody (Amersham) and a mouse antiExpress antibody
(Invitrogen, to identify proteins expressed from pCDNA3.1HisC).
 
Results
 
A Stable p52 Shc Expressing Cell Line Has Decreased 
Stress Fibers and Increased Migratory Capacity
 
Recent reports have identified a role for p52 Shc in inte- 
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grin signaling leading to cell cycle progression (Wary et al.,
1996). Since many of the signals that regulate mitogenesis
also promote cell migration (Pages et al., 1993; Cowley et
al., 1994; Olson et al., 1995; Anand-Apte et al., 1997;
Klemke et al., 1997), we reasoned that Shc might also play
a role in cell movement. To address this question, Cos-7
cells were stably transfected with wild-type murine p52
Shc cDNA. The resulting cells displayed an altered mor-
phology from the parental cell line. Phalloidin staining of
p52 Shc cells and parental Cos-7 cells revealed a decreased
number of actin-containing stress fibers in Shc-expressing
cells (Fig. 1), suggestive of a motile phenotype. The migra-
tory capacity of the parent and stable p52 Shc cells was
then assessed. Serum-deprived cells were allowed to mi-
grate in the absence of added cytokines using Boyden
chambers that had been coated on their lower surface with
collagen. As shown in Fig. 1, p52 Shc stable cells were ap-
proximately three times more migratory than the parental
cells. When the data from four independent experiments
were analyzed this difference was found to be statistically
significant (
 
P
 
 , 
 
0.05 by Student’s 
 
t
 
 test), suggesting that
Shc expression is associated with the haptotactic migratory
phenotype of these cells.
To extend these findings, we assessed the motility of
Cos-7 cells transiently expressing p52 Shc. Cells were se-
rum-deprived and allowed to migrate on either collagen or
vitronectin. As shown in Fig. 2, expression of p52 Shc was
sufficient to promote cell migration to an extent similar to
that seen with EGF, a strong migratory stimulus for these
cells (Klemke et al., 1998). In addition, Shc promoted a
similar migration response on collagen and vitronectin.
Data from several experiments demonstrated that both of
these responses were statistically significant (
 
P
 
 , 
 
0.01 by
Student’s 
 
t
 
 test). Cos-7 cells can use 
 
a
 
2
 
b
 
1 to migrate on
collagen (Klemke et al., 1997) suggesting that Shc’s ability
 
to transmit integrin-mediated signals for migration may be
more permissive than previously observed for cell cycle
progression (Wary et al., 1996). In agreement with the mo-
tility results, ligation of integrins with either collagen or
vitronectin resulted in tyrosine phosphorylation of wild-
type p52 Shc indicating that both of these ECM proteins
support Shc phosphorylation (Fig. 2).
Specific anti-integrin antibodies were used to determine
the integrin dependence of Shc’s effect upon motility. To
determine the role of the collagen receptors 
 
a
 
2
 
b
 
1 and
 
a
 
1
 
b
 
1 in this response, we first established concentrations
of 
 
a
 
1 (mAb 1973Z) and 
 
a
 
2
 
b
 
1 (6F1) monoclonal antibod-
ies that inhibited adhesion of Cos-7 cells to collagen (5 
 
m
 
g/
ml of anti-
 
a
 
1 and 10 
 
m
 
g/ml of anti-
 
a
 
2
 
b
 
1, data not shown).
Next, these concentrations of monoclonal antibodies were
added to the cells immediately before placement in Boy-
den chambers. Both anti-
 
a
 
1 antibodies and 
 
a
 
2
 
b
 
1 antibod-
ies inhibited Shc’s ability to promote cell migration; 
 
a
 
2
 
b
 
1
antibodies had a more pronounced effect (Fig. 3). These
data establish that 
 
a
 
2
 
b
 
1 and Shc can signal along a com-
mon pathway resulting in cell movement. P4C10, an anti-
body directed against the shared 
 
b
 
1 subunit, completely
inhibited haptotaxis of mock and Shc transfected cells on
collagen (data not shown). LM609, a function blocking
monoclonal antibody to 
 
a
 
v
 
b
 
3, prevented Shc-stimulated
migration towards vitronectin, but not on collagen (data
not shown), further confirming that Shc requires integrins
to effect cell movement.
To determine the nature of Shc-induced cell migration,
cells were allowed to migrate in Boyden chambers un-
der two experimental conditions. Chambers were either
coated with collagen on their lower surface to enable cells
to engage in haptotactic migration, or they were coated on
both their upper and lower surfaces to evaluate the ran-
dom motility of these cells. Shc was only able to signifi-
Figure 1. Decreased actin organization and increased migration of Shc expressing Cos-7 cells. (Left) Serum-deprived control and Shc
stably expressing cells were harvested, plated on collagen-coated coverslips for 2 h, fixed, permeabilized, and stained with rhodamine
phalloidin. The images shown are single confocal optical sections taken with a 633 objective (left). The scale bar is equal to 50 mm.
(Right) Migration of parental vs Shc-expressing Cos-7 cells. Serum-deprived cells were allowed to migrate for 4 h in Boyden chambers
towards a collagen matrix. Data from one of four independent experiments are shown (mean 6 SE). The enhanced migration of the Shc
cell line was found to be statistically significant (P , 0.05 by Student’s t test). Random migration towards BSA-coated chambers was al-
ways ,2% and subtracted from each value. 
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cantly enhance motility when chambers were coated on
the lower surface, demonstrating that Shc promotes hapto-
taxis and not random migration (Fig. 3 b).
 
Structural Requirements for Shc-induced Cell Motility
 
Having established a role for Shc in haptotaxis, mutational
analysis was performed to identify regions of Shc that me-
diate this response. Several point mutants were employed
for these studies (Fig. 4). To address the role of Shc
tyrosine phosphorylation in cell migration, increasing
amounts of cDNA encoding mutant forms of Shc bearing
tyrosine to phenylalanine point mutations at residues 239/
240 (Shc Y239F/Y240F), residue 317 (Shc Y317F) or both
residues 239/240 and residue 317 (ShcY239F/Y240F/
Y317F, Shc 3YF) were expressed in Cos-7 cells. With the
exception of Shc 3YF, these mutants were expressed to
similar extents as shown in Fig. 5 A. Next, cells expressing
these mutants were allowed to migrate on a collagen or
vitronectin substrate. Only wt Shc was found to signifi-
cantly enhance cell migration (
 
P
 
 , 
 
0.01 by analysis of vari-
ance [ANOVA] of six independent experiments). Neither
Y239/240F nor Y317F mutants stimulated motility sub-
stantially; although stimulation was observed by both of
these mutants in certain experiments, it was not found to
be statistically significant when all experiments were ana-
 
lyzed (
 
P
 
 . 
 
0.1 by ANOVA). The triple mutant, Shc 3YF,
was unable to induce cell motility on either matrix (Fig. 5
a) and appeared to suppress migration somewhat. There-
fore, tyrosine phosphorylation of both residues 239/240
and 317 appear to play a critical role in this response.
Shc’s phosphotyrosine binding domains, the PTB and
the SH2 domains, are known to be crucial for mitogenic sig-
naling through growth factor receptors (Gotoh et al., 1995;
Ricketts et al., 1996; Thomas and Bradshaw, 1997). Phos-
photyrosines on activated tyrosine kinase receptors can be
bound by these domains, thereby localizing Shc to the re-
ceptor (Bonfini et al., 1996). To determine whether these
domains might also be important for integrins to signal
through Shc, cells were transfected with varying amounts
Shc cDNAs containing point mutations selectively de-
signed to inhibit function of these domains. Shc S154P
contains a loss of function mutation in the PTB domain
that prevents interaction with activated insulin receptors
(Ricketts, 1999, and Gustafson, T., personal communica-
tion). Shc R401L contains a mutation in the conserved
phosphotyrosine binding FLVR motif of the Shc SH2
domain, rendering its SH2 domain non-functional (Mayer
et al., 1992). Mutation of the PTB domain (ShcS154P)
Figure 2. Shc stimulates migration on collagen and vitronectin.
(Top) Cos-7 cells were either mock transfected (pcDNA3.1HisC
plus lac z) or transfected with p52 Shc cDNA plus lac z. Cells
were deprived of serum and migration was assessed as indicated
with either migration media (mock, p52) or 100 ng/ml EGF
(Mock1EGF) in the lower chamber. Migration was quantitated
by enumerating the number of b-galactosidase positive cells/field
using a 203 objective. The mean 6 SE from a representative of
five independent experiments is shown. (Bottom) Tyrosine phos-
phorylation of p52 Shc in response to integrin ligation. Serum-
deprived cells expressing p52 Shc were harvested, then either
held in suspension or replated on collagen or vitronectin for 1 h
and lysed in RIPA buffer. His-tagged Shc was isolated with
nickel agarose beads and analyzed for phosphotyrosine content
by Western blot (mAb 4G10, upper autoradiogram). The blot
was then stripped and reprobed with an anti-Shc antibody as de-
scribed in Materials and Methods (lower autoradiogram).
Figure 3. Shc stimulates hap-
totactic migration. (Top) Shc-
stimulated cell migration
is integrin dependent. Cells
were processed for migration
assay as described in Materi-
als and Methods, except that
cells were mixed with anti-
integrin monoclonal antibod-
ies as indicated before load-
ing into Boyden chambers.
Next, cells were allowed to
migrate for 4 h and quanti-
tated for migration as de-
scribed above. Each bar rep-
resents the mean 6 SE from
one experiment representa-
tive of three with similar
results. (Bottom) Serum-
deprived mock or p52 Shc
transfected Cos-7 cells were
allowed to migrate on Boy-
den chambers coated on ei-
ther their lower surface (hap-
totaxis) or both their upper
and lower surfaces (random migration). Each bar represents the
mean 6 SE of a representative experiment performed in tripli-
cate.
Figure 4. Schematic of Shc constructs. Full-length p52 Shc is de-
picted. Gray, white, and hatched regions represent the NH2-ter-
minal PTB domain, the CH domain, and the SH2 domain respec-
tively. The point mutations used are indicated above the
schematic. Mutants are identified by S154P, Y239/Y240F, Y317F,
Y239/Y240/Y317F (Shc 3YF), and R401L. 
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blocked Shc’s ability to promote haptotaxis (Fig. 5 A). In
contrast, the Shc SH2 domain appeared to be dispensable
for migration, since ShcR401L consistently promoted mi-
gration as efficiently as wild-type Shc (Fig. 5 A). Analysis
of six independent experiments confirmed that the migra-
tion stimulated by Shc R401L was statistically significant
(
 
P
 
 , 
 
0.01 by ANOVA). The integrin-stimulated tyrosine
phosphorylation pattern of these Shc constructs correlated
with their ability to promote cell motility. For example,
wild-type and Shc R401L were phosphorylated in re-
sponse to cell adhesion while Shc 3YF and Shc S154P were
not. Once again, no differences were observed between
the migratory or tyrosine phosphorylation responses on
collagen and vitronectin in these studies (Fig. 5 B). In sum-
mary, expression of p52 Shc promotes motility of Cos-7
cells, and tyrosine phosphorylation and the PTB domain
are required for this response.
 
Shc Is Required for Haptotaxis of a Metastatic
Tumor Cell
 
To establish whether Shc might be required for cell migra-
tion in general, experiments were performed using the
constitutively migratory pancreatic carcinoma cell, FG-M.
These cells, selected for their migratory properties
 
 
 
in vitro,
acquired a metastatic phenotype in vivo
 
 
 
(Klemke et al.,
1998). Shc was constitutively tyrosine phosphorylated in
serum-deprived FG-M cells, even when cells are held in
suspension (Fig. 6). This is in contrast to Cos-7 cells, which
 
displayed adhesion-dependent Shc phosphorylation. There-
fore, we expressed migration incompetent forms of Shc
(Shc 3YF and Shc S154P) in FG-M cells to determine if
Shc was required for the migration of these cells. As
Figure 5. Mutational analysis
of Shc-stimulated migration.
(A) Cos-7 cells were
transfected with increasing
amounts of the indicated Shc
cDNAs (0.1, 0.3, and 3.0 mg/
10-cm plate), serum deprived
and assessed for haptotaxis
towards collagen. Each bar
represents the mean 6 SE of
a representative experiment.
Lysates were generated from
the cells used in these experi-
ments and analyzed by immu-
noblotting with polyclonal
anti-Shc antibodies. His-
tagged Shc can be discerned
from endogenous Shc in the
Western blot by its slightly re-
tarded mobility on the gel.
The 0.3 mg/plate condition
was repeated at least five
times for all the mutants with
similar results. Cell migration
induced by both p52wt and
R401L was found to be
highly statistically significant
(P , 0.01 by ANOVA). (B)
tyrosine phosphorylation pat-
tern of Shc mutants. Cells
were either held in suspension
or plated on collagen or vitronectin. As a positive control, cells were stimulated with insulin as indicated. His-tagged Shc was isolated af-
ter lysis in RIPA buffer by incubation with nickel agarose beads and analyzed by Western blotting with anti-phosphotyrosine. Blots
were then stripped and reprobed with pAb Shc.
Figure 6. Shc requirement
for haptotaxis in a metastatic
cell line. (A) Shc is constitu-
tively phosphorylated in hu-
man FG-M pancreatic carci-
noma cells. Serum-deprived
FG-M cells were either held
in suspension or plated on ex-
tracellular matrix proteins as
indicated for 30 min. Cells
were then lysed and analyzed
by immunoblotting with anti-
phosphotyrosine as described
in Materials and Methods.
(B) FG-M cells require Shc
tyrosine phosphorylation and
the Shc PTB domain for hap-
totaxis. FG-M cells were
transfected as indicated and
assayed for haptotaxis on vi-
tronectin by counting the
number of transfected cells/
high powered field. Each bar
represents the mean 6 SE from a single representative experi-
ment performed in triplicate. 
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shown in Fig. 6, haptotaxis in FG-M cells was highly Shc-
dependent, since expression of either Shc 3YF or Shc
S154P dramatically inhibited haptotaxis towards vitronec-
tin (by 76 and 83%, respectively). These results suggest
that Shc is required for the spontaneous, haptotactic phe-
notype of these cells.
 
Shc Is Not Required for Chemotaxis
 
Based on the findings that Shc appeared to be critical for
haptotaxis, studies were performed to investigate the role
of Shc in chemotaxis. In these experiments, cells express-
ing wild-type or mutant forms of Shc were allowed to mi-
grate in collagen coated Boyden chambers towards a gra-
dient of EGF. The EGF response was quantitated by
dividing the number of migratory cells observed in the
presence vs the absence of EGF for each experimental
condition. In mock transfected cells, addition of EGF-
stimulated a 2.6-fold increase in migration relative to that
observed in its absence. Both wt Shc and Shc R401L sub-
stantially increased the number of migratory cells ob-
served in the absence of growth factor, as discussed above.
Stimulation of the EGF receptor increased this number
further, generating an EGF response of approximately
twofold. Surprisingly, Shc was not required for EGF-stim-
ulated motility since expression of either Shc 3YF or Shc
S154P failed to block EGF-induced increases in cell migra-
tion (Fig. 7). Similar results were observed when IGF-1
was used to stimulate migration (data not shown). There-
fore, Shc appears to play a preferential role in haptotaxis
as it is not required for the chemotactic response of these
cells.
 
Shc Promotes Growth Factor–induced Mitogenesis Yet 
Fails to Stimulate Anchorage-dependent
DNA Synthesis
 
The role of Shc in mitogenic signaling by growth factor
receptors is well established (Bonfini et al., 1996). In
nontransformed cells, integrin ligation and Shc phosphor-
ylation is required for ERK activation and cell cycle pro-
gression even in the presence of growth factors (Wary et
al., 1996). That Shc was able to mimic growth factor effects
on cell migration suggests it may also regulate DNA syn-
thesis under conditions of serum deprivation. To test this
possibility, Cos-7 cells were transfected with either wild-
type or mutant forms of Shc and then assessed for BrdU
incorporation in the absence of exogenous growth factor
addition. As shown in Fig. 8, Shc did not regulate DNA
synthesis under these growth conditions as wild-type or
mutant forms Shc failed to influence BrdU incorporation.
Thus, in the absence of exogenous growth factors, Shc ex-
pression was not sufficient to promote proliferation even
though it was able to induce haptotactic cell migration un-
der these conditions.
Whereas Shc does not influence anchorage-dependent
DNA synthesis, previous studies have documented that
Shc is crucial for proliferation (Bonfini et al., 1996). Inter-
estingly, the Shc requirements for mitogenesis and hapto-
taxis are not identical. As shown in Fig. 8, mutation of ei-
ther tyrosines 239/240 or 317 alone or in combination
completely inhibited EGF’s ability to increase DNA syn-
thesis, suggesting non-redundant function of these sites for
cell cycle progression. Expression of Shc R401L, which in-
duced haptotaxis to the same extent as wild-type Shc, in-
hibited EGF-stimulated DNA synthesis. In contrast to its
effect on haptotaxis, Shc S154P did not affect EGF-stimu-
lated proliferation. Thus, the Shc SH2 domain selectively
transduces mitogenic signals in response to EGF, while the
PTB domain is critical for haptotaxis.
 
Discussion
 
Cell migration and proliferation are required for wound
healing, embryonic development, and angiogenesis. The
observation that, during these processes, cells can either
migrate in the absence of proliferation or proliferate with-
out migrating necessitates the existence of signaling path-
ways that distinguish between these two responses (Hen-
derson and Copp, 1997; Martin, 1997; Perris, 1997; Risau,
1997). In this report evidence is provided that the adaptor
protein, p52 Shc, participates in this decision-making pro-
cess. Under growth factor–limiting conditions, Shc was re-
quired for haptotaxis, but did not influence DNA synthe-
sis. In contrast, when growth factors were present, Shc was
Figure 7. Shc is not required
for EGF-stimulated cell mi-
gration. Cos-7 cells were
transfected with cDNAs en-
coding Shc mutants as indi-
cated, serum deprived, and
assayed for migration in the
presence of 100 ng/ml EGF as
described in Materials and
Methods. The data are de-
picted as relative migration,
with the migration induced by
the indicated forms of Shc in
the absence of EGF defined as one. Each bar represents the
mean  6  SE of four independent experiments performed in dupli-
cate. None of the differences between the groups were found to
be statistically significant.
Figure 8. Shc is required for
EGF to stimulate anchorage-
dependent DNA synthesis.
Cos-7 cells were transfected
with the indicated cDNAs,
serum deprived and assayed
for BrdU incorporation in ei-
ther the absence (top) or the
presence of 100 ng/ml EGF
(bottom). The data are pre-
sented as the percentage of
transfected cells incorporat-
ing BrdU (top) or as percent
increase in BrdU incorpora-
tion stimulated by the addi-
tion of EGF (bottom). Each
bar represents the mean 6
SD of three independent ex-
periments performed in trip-
licate. 
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crucial for proliferation, but failed to impact cell migra-
tion. Shc’s phosphotyrosine binding domains were differ-
entially required for these responses; the PTB transduced
migratory signals, while the SH2 was required for mito-
genesis.
Shc’s signaling capacity is regulated by tyrosine phos-
phorylation. After activation of growth factor receptors
and cytosolic tyrosine kinases, Shc becomes phosphory-
lated (McGlade et al., 1992; Pelicci et al., 1992) on residues
239/240 and 317 within the CH domain and binds Grb2
(Rozakis-Adcock et al., 1992; Salcini et al., 1994; Gotoh et
al., 1996; van der Geer et al., 1996), ultimately resulting in
the activation of Ras and ERK. However, the biologi-
cal role of these residues in integrin signaling remains un-
clear. Recent reports have demonstrated a requirement
for Shc Y317 for integrin-mediated ERK activity (Wary et
al., 1996), while another report suggested that integrins
can stimulate the ERK pathway independently of Y317
(Schlaepfer et al., 1998). In the current report, mutation of
either of these sites alone resulted in a loss of Shc’s ability
to stimulate migration, suggesting that integrins can utilize
both of these sites. Tyrosines 239/240 and 317 were crucial
for EGF-stimulated mitogenesis in Cos-7 cells, in agree-
ment with findings of others that these sites couple to dis-
tinct effectors in mitogenic signaling (Gotoh et al., 1996,
1997). In summary, Shc tyrosine phosphorylation does not
distinguish between proliferative and cell migratory sig-
naling pathways.
The observation that cytoskeletally associated kinases
phosphorylate Shc (McGlade et al., 1992; Schlaepfer et al.,
1998; Wary et al., 1998) suggests that recruitment of Shc to
the actin-associated cytoskeleton is an important step in
integrin signaling. Recent studies defined a role for the
SH3 domain of the Src family member Fyn in this process
(Wary et al., 1998). Presumably, the Fyn SH3 domain in-
teracts with proline-rich regions in the CH domain of Shc.
The PTB domain may also contribute to Shc recruitment.
The amino-terminal domain of Shc was reported to medi-
ate the association of this adaptor protein to an actin-rich
cellular fraction (Thomas et al., 1995). In agreement with
this report, we find that mutation of the PTB domain abol-
ishes integrin-stimulated Shc tyrosine phosphorylation;
the SH2 domain is dispensable for this process. The PTB
can bind phospholipids (Zhou et al., 1995) which enhances
Shc phosphorylation by cSrc (Sato et al., 1997). Taken to-
gether, these observations suggest a model in which the
PTB domain localizes Shc to the membrane where it be-
comes phosphorylated by cytoskeletally associated ty-
rosine kinases, such as Src, Fyn and/or FAK after integrin
ligation, which ultimately results in cell migration.
While Shc-dependent cell migration and proliferation
depend upon tyrosine phosphorylation, these processes
can be distinguished by their differential requirement for
Shc’s phosphotyrosine binding domains. The SH2 domain
is selectively required for proliferation, as mutation of this
domain dramatically inhibited EGF-stimulated DNA syn-
thesis but had no effect on motility, or integrin-induced
Shc phosphorylation. The PTB domain, in contrast, medi-
ated tyrosine phosphorylation of Shc in response to inte-
grin ligation and haptotactic cell migration. These findings
may be biologically relevant for a number of processes.
For example, Shc may play an important role during neu-
 
ral crest cell migration, when cells migrate along a hap-
totactic gradient without proliferating (Henderson and
Copp, 1997) or during wound healing when fibroblasts mi-
grate in a fibrin-rich ECM (Martin, 1997). However, when
cells reach areas of high growth factor concentration, Shc
may facilitate the cell proliferation response. Activation of
the EGF receptor promotes the redistribution of Shc from
a perinuclear to a plasma membrane localization (Lotti et
al., 1996). EGF-R phosphorylation is required for this ef-
fect, presumably because receptor activation creates con-
sensus binding sites for Shc’s phosphotyrosine binding do-
mains (Lotti et al., 1996). Thus, when growth factors are
present, Shc may be recruited from areas where it trans-
duces haptotactic signals, such as integrin containing focal
contacts, to regions of the membrane containing growth
factor receptors where it participates in mitogenic sig-
naling.
In summary, proliferation and motility are controlled by
adhesion proteins and growth factors associated with the
ECM (Martin, 1997). Integrin and growth factor receptor
signals signal through the adaptor protein Shc to regulate
these responses (Bonfini et al., 1996; Wary et al., 1996,
1998). We find that migratory and proliferative signals also
bifurcate at the level of Shc. This divergence is character-
ized by differential requirements of the Shc PTB domain
and the Shc SH2 domain.
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